A*STAR Mass Spectrometry ClusterAdvancing science through leveraging mass spec capabilities across BMRC – in Research, Collaboration, Industry Partnership and Services.
The A*STAR Mass Spectrometry Cluster brings together a wealth of mass spec capabilities from across the Biomedical Research Council of A*STAR. Through the coordination of 30 high-end instruments across 7 existing well-established
mass spec platforms, spanning 4 Research Institutes, the cluster ensures that scientists needs are met whilst ensures efficiency in spending, reduces unnecessary duplication and maximises utilisation of valuable resources.
Capabilities include mass spec capabilities optimised for a comprehensive range of applications within proteomics (functional and expression), biomanufacturing (biopharma and analytics) and small molecules (including food science,
pharma, bioprocess and human health).
The cluster’s team of dedicated expert staff are able consult, train, support and offer high-quality service to scientists via a range of access models (including self-use, service and collaborative projects). The cluster
is supported by the Research Support Centre (RSC) for front office (e.g. marketing, enquiry handling) and back-office functions (e.g. invoicing, reporting) to ensure a professional service.
Enabling open access to this wealth of
mass spectrometry instruments and expertise
Biologics product characterisation
Quantitative proteomics (SILAC; SWATH-MS)
Target proteomics / SRM / MRM / PRM
Human health and disease
|Data Independent||Target Analytics|
- Data Independent Acquisition / SWATH
- Metabolite Tracing / Metabolic Labelling
- Structural Elucidation
- Quantitative / Qualitative Analysis
- Clinical Proteomics / Metabolomics
- Customised Data Analytics
- Single / Multiple / Parallel Reaction Monitoring
- Metabolite Tracing
Research Institutes & Supporting Platforms
For more details about the programme and potential collaborations, please contact firstname.lastname@example.org